Anixa Biosciences
ANIX

Anixa Biosciences (ANIX) earnings history

Most recent quarter

Period end
Jul 31, 2025
EPS actual
−$0.08
EPS estimate
−$0.08
EPS surprise
−4.54%
Revenue
$0.00
Reported
Sep 10, 2025

Earnings history

PeriodReportedEPS estimateEPS actualSurpriseRevenueFiling
Q3 2025Sep 10, 2025−$0.08−$0.08−4.54%$0.00SEC
Q2 2025May 28, 2025−$0.09−$0.09+3.54%$0.00SEC
Q1 2025Mar 11, 2025−$0.08−$0.10−25.00%$0.00SEC
Q4 2024Jan 10, 2025−$0.09−$0.09−5.88%$0.00SEC
Q3 2024Sep 6, 2024−$0.09−$0.10−17.65%$0.00SEC
Q2 2024Jun 4, 2024−$0.11−$0.10+9.09%$0.00SEC
Q1 2024Mar 12, 2024−$0.09−$0.10−11.11%$0.00SEC
Q4 2023Jan 16, 2024−$0.09−$0.09+0.00%$0.00SEC
Q3 2023Sep 6, 2023−$0.09−$0.08+11.11%$0.00SEC
Q2 2023Jun 14, 2023−$0.12−$0.10+17.39%$100,000.00SEC
Q1 2023Mar 17, 2023−$0.16−$0.08+50.00%$0.00SEC
Q4 2022Jan 4, 2023−$0.11−$0.11+0.00%$0.00SEC
Q3 2022Sep 9, 2022−$0.13−$0.09+30.77%$0.00
Q2 2022Jun 10, 2022−$0.13−$0.12+7.69%$0.00
Q1 2022Mar 11, 2022−$0.13−$0.13+0.00%$0.00
Q3 2021Sep 1, 2021−$0.14−$0.14+0.00%$0.00
Q1 2020Mar 9, 2020−$0.13−$0.13+0.00%$0.00

Quarterly revenue

Q1 2020
$0.00
Q3 2021
$0.00
Q1 2022
$0.00
Q2 2022
$0.00
Q3 2022
$0.00
Q4 2022
$0.00
Q1 2023
$0.00
Q2 2023
$100,000.00
Q3 2023
$0.00
Q4 2023
$0.00
Q1 2024
$0.00
Q2 2024
$0.00
Q3 2024
$0.00
Q4 2024
$0.00
Q1 2025
$0.00
Q2 2025
$0.00
Q3 2025
$0.00

Frequently asked questions

  • When did Anixa Biosciences (ANIX) last report earnings?

    Anixa Biosciences last reported on Sep 10, 2025, covering fiscal Q3 2025.

  • Did ANIX beat earnings estimates?

    No. Anixa Biosciences reported EPS of −$0.08 for Q3 2025 against a −$0.08 estimate — a 4.54% miss.

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.